Prestige Consumer Healthcare (PBH) Free Cash Flow (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Free Cash Flow came in at $75.3 million in Q4 2025, up 18.47% year-on-year from $63.5 million in Q4 2024, and up 35.89% quarter-over-quarter from $55.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Free Cash Flow (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Free Cash Flow history runs 16 years deep, the most recent figure standing at $75.3 million for Q4 2025.
- On a quarterly basis, Free Cash Flow rose 18.47% year-over-year to $75.3 million in Q4 2025; TTM through Dec 2025 was $267.2 million, a 7.44% increase from a year earlier, with the FY2025 full-year figure at $243.3 million, up 1.64% from the prior year.
- Free Cash Flow advanced to $75.3 million in Q4 2025 per PBH's latest filing, from $55.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $78.2 million in Q2 2025 and bottomed at $46.6 million in Q2 2023.
- The 5-year median for Free Cash Flow is $59.0 million (2021), against an average of $60.9 million.
- Across the five-year window, Free Cash Flow surged 47.29% in 2021 and slipped 18.51% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at $64.1 million in 2021, then fell by 17.06% to $53.1 million in 2022, then jumped by 30.74% to $69.5 million in 2023, then declined by 8.57% to $63.5 million in 2024, then gained by 18.47% to $75.3 million in 2025.
- Per Business Quant, the three latest PBH Free Cash Flow figures stand at $75.3 million (Q4 2025), $55.4 million (Q3 2025), and $78.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 75.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.26 Mn |
| Dec 31, 2025 | 75.26 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Jun 30, 2025 | 78.18 Mn |
| Jun 30, 2025 | 78.18 Mn |
| Mar 31, 2025 | 58.37 Mn |
| Mar 31, 2025 | 58.37 Mn |
| Dec 31, 2024 | 63.53 Mn |
| Dec 31, 2024 | 63.53 Mn |
| Sep 30, 2024 | 67.77 Mn |
| Sep 30, 2024 | 67.77 Mn |
| Jun 30, 2024 | 53.62 Mn |
| Jun 30, 2024 | 53.62 Mn |
| Mar 31, 2024 | 63.76 Mn |
| Mar 31, 2024 | 63.76 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Sep 30, 2023 | 59.53 Mn |
| Sep 30, 2023 | 59.53 Mn |